isocitric acid has been researched along with Glioma in 3 studies
isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Lv, W | 1 |
| Li, Q | 1 |
| Wang, Q | 1 |
| Ru, Y | 1 |
| Xiong, X | 1 |
| Yan, F | 1 |
| Pan, T | 1 |
| Lin, W | 1 |
| Li, X | 1 |
| Kato, Y | 1 |
| Smeitink, J | 1 |
1 review available for isocitric acid and Glioma
| Article | Year |
|---|---|
Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.
Topics: Antibodies, Monoclonal; Arginine; Biomarkers, Tumor; Brain Neoplasms; Catalysis; Cytosol; Glioma; Gl | 2015 |
2 other studies available for isocitric acid and Glioma
| Article | Year |
|---|---|
IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.
Topics: Carcinogenesis; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; HC | 2019 |
Metabolism, gliomas, and IDH1.
Topics: Brain Neoplasms; Genetic Markers; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Isocitrates; | 2010 |